by Darcy Birse, PhD, Dan Lacroix, PhD, Michael Dyck, PhD, François Pothier, PhD, and Marc-André Sirard, PhD, DMV
Volume 3, Issue 2 (March/April 2004)
The biopharmaceutical manufacturing sector is rapidly gearing up production capacity to satisfy the steadily escalating global demand for complex biologics to combat a number of treatable illnesses. Frequently, the biotherapeutics in demand are too complicated to be chemically synthesized and thus are beyond the reach of traditional pharmaceutical approaches. To effectively address this issue, these products must be developed and produced using viable and robust biological systems…
Citation:
Birse D, Lacroix D, Dyck M, Pothier F, Sirard M. Biotherapeutics from Transgenic Porcine Sources: Bioprocessing Approaches and Challenges. BioProcess J, 2004; 3(2): 37-44.